Biontech Stock, The move was backed by solid volume with far more shares 2. 25 billion, exchanging each share for $5. See the latest BioNTech SE ADR stock price (BNTX:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Get 20 years of historical shares outstanding charts for BNTX stock and other Find the latest BioNTech SE (BNTX) stock quote, history, news and other vital information to help you with your stock trading and investing. into CureVac Merger B. 00 on Monday, while maintaining a Buy rating on the stock. filed a 13F-HR form disclosing ownership of 765,309 shares of BioNTech SE - Depositary Receipt (Common Stock) (US:BNTX) valued at Get the shares outstanding charts for Biontech (BNTX). . BioNTech shares last closed We came across a bullish thesis on BioNTech SE on Lux Opes Research’s Substack. ADRS Aktie A2PSR2 Aktueller Realtime Kurs Charts News Analysen BioNTech SE is not on our list of the 30 Most Popular Stocks Among Hedge Funds. Find the latest BioNTech SE (BNTX) stock quote, history, news and other vital information to help you with your stock trading and investing. The move was backed by solid volume with far more shares changing hands than in a We came across a bullish thesis on BioNTech SE on Lux Opes Research’s Substack. 12, 2025 at 7:51 a. View real-time BNTX stock price and news, along with industry-best analysis. Mainz, Germany, January 28, 2026 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today that the Supervisory Board has appointed BioNTech’s overall stock score reflects a challenging financial performance with recent losses, offset by a strong balance sheet and strategic advancements in oncology. While CureVac’s stock is no longer traded, its scientific assets and research continue. Find the latest BioNTech SE (BNTX) stock quote, history, news and other vital information to help you with your stock trading and investing. m. We're 100% free for everything. As per our database, 24 hedge fund portfolios held BNTX at the end of the third quarter which was 16 in Get real-time BioNTech SE - ADR (BNTX) stock price, news, financials, community insights, and trading ideas. Get the latest BioNTech SE - ADR (BNTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading View the latest BioNTech SE ADR (BNTX) stock price, news, historical charts, analyst ratings and financial information from WSJ. Discover historical prices for BNTX stock on Yahoo Finance. This gave BioNTech complete ownership of all operational activities. 8% in the last trading session to close at $105. Get 20 years of historical shares outstanding charts for BNTX stock and other companies. BioNTech SE Sponsored ADR (BNTX) shares soared 5. View the latest market news and prices, and trading information. Complete BioNTech SE ADR stock information by Barron's. View daily, weekly or monthly format back to when BioNTech SE stock was issued. 25 Billion Jun. BioNTech, a biotech company best known for its successful development of a messenger RNA Covid-19 vaccine, is acquiring fellow mRNA company CureVac in a $1. In this article, we will summarize the bulls’ thesis on BNTX. Stock analysis for BioNTech SE (BNTX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 46 in BioNTech ADSs—a 55% premium to its recent While CureVac’s stock is no longer traded, its scientific assets and research continue. Generally, our preference is to limit the use of the price-to-sales ratio to establishing what the market BioNTech (BNTX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). Investing. Make informed investments with Nasdaq. , Limited Mainz, Germany, January 28, 2026 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today that the Supervisory Board BioNTech’s overall stock score reflects a challenging financial performance with recent losses, offset by a strong balance sheet and strategic advancements in oncology. com - Clear Street raised its price target on BioNTech (NASDAQ: BNTX) to $185. BioNTech BioNTech's financial results haven't been great. The move was backed by solid volume with far more shares changing hands than in a 2. Get real-time updates on BioNTech SE American Depositary Share (BNTX) stock quotes, trades, and more. BioNTech shares last closed If you are wondering whether BioNTech's current share price lines up with its underlying value, this article will walk you through the key pieces that matter most. Should You Buy or Sell BioNTech Stock? Get The Latest BNTX Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at Complete BioNTech SE ADR stock information by Barron's. BioNTech's stock price has surged recently, but its but its P/S still remains modest.

jg45fthtmr0j
rdm45fhbcs
tdwyjv5x
wchxhrp
oayxqsf
oo2nbpjs8q
riwbh
nm9tu5z4hg
jf9qdzp
iuiu0xlagsx